Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs

Area of Science:

• Microbiology
• Immunology
• Infectious Diseases

Background:

• Tuberculosis (TB) vaccine development predominantly relies on laboratory strains (H37Rv, Erdman) for animal testing.
• Naturally occurring Mycobacterium tuberculosis (M. tuberculosis) clinical isolates exhibit significant genotypic and phenotypic diversity.
• Limited understanding exists regarding the virulence and pathogenicity of diverse M. tuberculosis clinical isolates in vivo.

Purpose of the Study:

• To compare the in vivo pathogenicity and virulence of various M. tuberculosis clinical isolates.
• To assess the variability in disease manifestation caused by drug-sensitive and multi-drug resistant (MDR) strains in a guinea pig model.

Main Methods:

• Standardized aerosol infection model using guinea pigs.
• Comparison of clinical M. tuberculosis isolates, including Beijing and non-Beijing, drug-sensitive, and MDR strains.
• Evaluation of virulence based on bacterial load, lesion development (pulmonary and extra-pulmonary), and survival rates.

Main Results:

• Clinical M. tuberculosis isolates demonstrated a broad spectrum of virulence in the guinea pig model.
• Certain isolates induced severe necrosis and atypical cavitary lesions in lungs and lymph nodes.
• The two MDR-TB strains tested exhibited lower virulence compared to other clinical isolates.

Conclusions:

• The significant variability in virulence among clinical M. tuberculosis strains challenges the predictive value of current TB vaccine testing.
• Future TB vaccine efficacy studies must incorporate diverse clinical isolates to ensure broad protection against naturally occurring infections.
• The guinea pig model is suitable for evaluating the pathogenicity of clinical M. tuberculosis strains and assessing vaccine effectiveness against diverse isolates.